Disappointing Earnings, New Lawsuit Phase Mark Two DeCode Anniversaries | GenomeWeb

Cepheid Reports Soaring Product Sales in Q3 as Revenue More Than Doubles

Cepheid’s revenues more than doubled during the third quarter, driven by increased product sales, the company reported this week. However, this surge was almost eaten up by soaring costs of product sales, resulting in a slightly reduced net loss.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.